NCT07723482: ML-016 in Advanced Cancer With Lung and/or Liver Involvement
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 108 planned
- Started
- 25 Sep 2026
- Primary completion
- Oct 2027
- Arms
- ML-016 Monotherapy
- Results
- None posted
- 23 Jul 2026: Trial registered
- 25 Sep 2026: Trial started